[7] However, FDA labeling for both semaglutide and tirzepatide includes warnings about acute kidney injury, particularly in patients experiencing severe gastrointestinal adverse effects
Food and Drug Administration approved an oral formulation of Semaglutide for weight management, allowing it to enter the obesity treatment market
In my work, Ive found that most of my clients with Hashimotos have low or no stomach acid, which impairs their ability to digest protein foods
These seem to be the mechanisms by which ROS participate in the induction of low-grade chronic inflammation, cellular dysfunction, and implicitly in the promotion and aggravation of chronic conditions (e.g., cardiovascular, pulmonary, renal, metabolic, neurological, malignancies) ( Regarding kidney damage, OS is correlated in the literature with both antioxidant depletion and excessive ROS production, serving as both a cause and an effect of renal degradation
&
Meanwhile, as this segment of the population focuses on themselves, Circana uncovered a decline in many pet segments outside of pet food. Circana also found that certain retail channels resonate with GLP-1 users, as their spending tends to shift away from mass and dollar stores and toward club stores and e-commerce retailers during their first year of active usage of the medication
)
)
)
